The key equity barometers failed to hold on to gains and turned negative in mid-morning trade. The Nifty traded below the 15,750 mark. Pharma shares, however, extended rising streak for second consecutive session.
At 11:22 IST, the barometer index, the S&P BSE Sensex, was down 41.51 points or 0.08% to 52,652.06. The Nifty 50 index lost 10.60 points or 0.07% to 15,721.50.
In the broader market, the S&P BSE Mid-Cap index rose 0.48% while the S&P BSE Small-Cap index added 0.59%.
The market breadth, indicating the overall health of the market, was strong. On the BSE, 1915 shares rose and 1159 shares fell. A total of 125 shares were unchanged.
Volatility persisted in markets across the globe ahead of the US Fed's decision on interest rates, which will be announced later today. Friday's red-hot inflation data from the US has raised the market expectations of an interest rate hike by 75 basis points, the largest in 28 years.
Buzzing Index:
The Nifty Pharma index rose 0.41% to 12,268.10. The index has added 0.63% in two sessions.
Strides Pharma Science (up 2.24%), Ipca Laboratories (up 1.37%), Gland Pharma (up 1.19%), Natco Pharma (up 1.17%), and Divis Laboratories (up 1.11%) were the top index gainers.
Among the other gainers were Alkem Laboratories (up 0.95%), Cipla (up 0.82%), Lupin (up 0.69%), Glenmark Pharmaceuticals (up 0.45%) and Sun Pharmaceuticals Industries (up 0.22%).
Global markets:
Asian stocks were trading mixed on Wednesday, following overnight losses on Wall Street as the S&P 500 fell deeper into bear market territory.
China's industrial output climbed 0.7% in May as compared with a year earlier, official data showed Wednesday, rising from the April's 2.9% decline. Meanwhile, retail sales in May fell 6.7% year-on-year.
However, as Beijing saw clusters of COVID-19 outbreaks, the Beijing authorities warned on Tuesday that the city was in a "race against time", adding to worries that the resumption of stringent curbs could hurt its economy and global supply chain.
U.S. stock indexes had a mixed Tuesday on fears that red-hot inflation will prompt more aggressive rate increases from the Federal Reserve. The S&P 500 tumbled 0.38% to close at 3,735.48. The Dow Jones Industrial Average dropped 151.91 points, or 0.5%, to settle at 30,364.83. The Nasdaq Composite rose 0.18% to finish at 10,828.35.
Recession fears in the US continued to loom large ahead of the US Fed's policy outcome due on Wednesday. A major foreign brokerage has reportedly forecast a 75-basis point (bp) interest rate hike from the Fed's June policy meeting on Wednesday. A 75-bp hike would reportedly be the biggest since 1994.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app